| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/24/2011 | US20110047633 Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046213 Production of Delta 9 Tetrahydrocannabinol |
| 02/24/2011 | US20110046210 Substituted thiopenecarboxamides as ikk-beta serine-, threonine-protein kinase inhibitors |
| 02/24/2011 | US20110046200 Use of antisense oligonucleotides to effect translation modulation |
| 02/24/2011 | US20110046190 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 02/24/2011 | US20110046184 Solid state forms of racemic ilaprazole |
| 02/24/2011 | US20110046183 Crystal of benzimidazole compound |
| 02/24/2011 | US20110046174 Kappa-opiate agonists for the treatment of diarrhea-predominant irritable bowel syndrome |
| 02/24/2011 | US20110046171 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046096 Novel piperazino-dihydrothienopyrimidine derivatives |
| 02/24/2011 | US20110046086 Composition Comprising Polysaccharide Extracted from Panax Ginseng Preventing and Treating Liver Diseases |
| 02/24/2011 | US20110046084 Exopolysaccharide |
| 02/24/2011 | US20110046081 Classical cannabinoid metabolites and methods of use thereof |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110046072 Solid pharmaceutical formulation with delayed release |
| 02/24/2011 | US20110046047 Bone Morphogenetic Proteins for Appetite Control |
| 02/24/2011 | US20110045107 Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines |
| 02/24/2011 | US20110045088 Intranasal granisetron and nasal applicator |
| 02/24/2011 | US20110045077 Encapsulated pancreatic islet cell products and methods of use thereof |
| 02/24/2011 | US20110045073 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 02/24/2011 | US20110045068 Pharmaceutical formulations for the oral administration of ppi |
| 02/24/2011 | US20110045066 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 02/24/2011 | US20110045033 Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders |
| 02/24/2011 | US20110045025 Pharmaceutical Compositions Containing Clostridium Difficile Toxoids A and B |
| 02/24/2011 | US20110045014 Acceleration agent of calcium absorption |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044973 Treatment of cystic disease with lysophosphatidic acid antagonists |
| 02/24/2011 | US20110044969 Antimicrobial Agents for the Treatment of Campylobacter Species in the Crop of a Bird |
| 02/24/2011 | US20110044960 Medicament, dental material, and method of screening |
| 02/24/2011 | US20110044917 Dental composition for treating peri-implantitis |
| 02/24/2011 | US20110044915 Confectionery containing algae for the prevention of oro-dental infections |
| 02/24/2011 | US20110044914 Cleaning compositions and methods |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | DE102009037551A1 Cyclosporinderivate Cyclosporin derivatives |
| 02/24/2011 | CA2771445A1 Novel fxr (nr1h4) binding and activity modulating compounds |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2286836A1 Immunostimulating agent |
| 02/23/2011 | EP2286829A1 Drug, dental material, and screening method |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286817A2 Method of treating functional bowel disorders |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286810A1 Pharmaceutical composition for treatment of fibromyalgia |
| 02/23/2011 | EP2286807A2 Medicament for preventive and/or therapeutic treatment of adhesion of bowel |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2285390A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP2285347A2 Compositions and methods for treating digestive disorders |
| 02/23/2011 | EP2285344A1 Sweet containing algae for the prevention of oro-dental infections |
| 02/23/2011 | EP1801209B1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 02/23/2011 | EP1697360B1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt. |
| 02/23/2011 | EP1505989B1 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | CN1989108B Method for producing carbostyryl compound |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101979639A Dendrobium polysaccharide with hypoglycemic activity and extracting method thereof |
| 02/23/2011 | CN101979595A Dual expression vector for immunostimulatory RNA and HBV target gene silence RNA, construction and application thereof |
| 02/23/2011 | CN101979558A Small interfering RNA (siRNA) molecule of targeted hepatitis B virus (HBV) gene and application thereof |
| 02/23/2011 | CN101979557A SiRNA molecule and application thereof to antiviral medicaments |
| 02/23/2011 | CN101979556A Small interfering ribose nucleic acid (siRNA) targeting molecule and application thereof |
| 02/23/2011 | CN101979555A Small interference RNA molecule and application thereof |
| 02/23/2011 | CN101979554A siRNA molecule interfering HBV gene and application thereof |
| 02/23/2011 | CN101979553A siRNA molecule for interfering HBV gene and antiviral application thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979405A Immune dominant HLA-A3 super-type restrictive CTL epitope of hepatitis B virus core antigen and identification method and application thereof |
| 02/23/2011 | CN101979403A Novel broad caspase inhibitor and preparation method and application thereof |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101979084A Chinese medicinal composition for warming kidney and tonifying yang and preparation method thereof |
| 02/23/2011 | CN101979079A Medicament for treating astriction |
| 02/23/2011 | CN101979073A Medicament for soothing liver and regulating Qi |
| 02/23/2011 | CN101979072A Chinese medicament for treating chronic liver disease |
| 02/23/2011 | CN101979070A Chinese medicament for treating hepatitis B |
| 02/23/2011 | CN101979061A Antiemetic medicine |
| 02/23/2011 | CN101979054A Traditional Chinese medicine for treating diabetic constipation |
| 02/23/2011 | CN101979051A Traditional Chinese medicine for treating chronic gastritis |
| 02/23/2011 | CN101979030A Chinese medicinal ointment formula and preparation method and application thereof |
| 02/23/2011 | CN101979023A Chinese medicine for curing chronic hepatitis |
| 02/23/2011 | CN101979009A Chinese medicament for treating spleen deficiency |
| 02/23/2011 | CN101979006A Chinese medicament for treating chronic hepatitis |
| 02/23/2011 | CN101979005A Medicament for treating gastroptosis |
| 02/23/2011 | CN101979000A Traditional Chinese medicinal prescription for quickly treating lithiasis |
| 02/23/2011 | CN101978999A Medicament for treating icteric hepatitis |
| 02/23/2011 | CN101978998A Medicinal composition for disintoxicating and protecting liver and preparation method thereof |
| 02/23/2011 | CN101978995A Medicament for treating toothache |